The discovery of the relationship between SV2A and epilepsy triggered the development of the first SV2A radiotracer, [3H]ucb 30889, with the aim to identify levetiracetam’s binding sites in the rat brain and spinal cord (Gillard et al., 2003; Lambeng et al., 2005). The gene discussed is SV2A; the disease is epilepsy.